EVERYTHING ABOUT MBL77

mutations given the fact that, as explained below, CLL therapy is predicated over the presence or absence of such mutations. The present consensus is that, apart from clonal mutations, subclonal mutations with a variant allelic frequency starting from five to 10% (and thus beneath the brink of detection by standard molecular tactics) may be noted,